Cart
sales@molnova.com
PF-4878691
CAS No. 532959-63-0
PF-4878691( 3M-852A )
Catalog No. M24509 CAS No. 532959-63-0
PF-4878691 is an effective and selective Toll-like receptor 7 agonists modelled. It is used to dissociate its antiviral and inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 368 | In Stock |
|
| 10MG | 536 | In Stock |
|
| 25MG | 872 | In Stock |
|
| 50MG | 1161 | In Stock |
|
| 100MG | 1593 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-4878691
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-4878691 is an effective and selective Toll-like receptor 7 agonists modelled. It is used to dissociate its antiviral and inflammatory activities.
-
DescriptionPF-4878691 is an effective and selective Toll-like receptor 7 agonists modelled. It is used to dissociate its antiviral and inflammatory activities.
-
In Vitro——
-
In VivoAnimal Model:BALB/c mice , C57bl/6 J mice Dosage:30 mg/kg, 60 mg/kg, 90 mg/kg, 150 mg/kg Administration:Oral gavage (p.o.)Result:Induced dose and time dependant lymphopenia and 2,5,oligoadenylate synthetase (2,5,OAS).Caused cardiovascular changes. Significantly increased TLR7 receptor RNA.
-
Synonyms3M-852A
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number532959-63-0
-
Formula Weight361.46
-
Molecular FormulaC17H23N5O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:19.23 mg/mL (53.20 mM; Need ultrasonic)
-
SMILESCCc1nc(c(N)nc2ccccc22)c2n1CCCCNS(C)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fidock MD, et al. The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691). Clin Pharmacol Ther. 2011 Jun;89(6):821-9.
molnova catalog
related products
-
SM-276001
SM-276001 is a potent selective agonist of TLR7,and is an orally active interferon (IFN) inducer.
-
ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE(receptor for advanced glycation end products) and TLR4 (toll-like receptor 4). ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI).
-
Poly(I:C)
Poly (I:C) is a synthetic double-stranded RNA (dsRNA) analog and is an immunostimulant that acts as the most potent interferon (IFN) inducer. It also is a Toll-like receptor- 3 (TLR3) agonist.Mixtures that included the TLR7/8 agonists R848 or CL075, combined with the poly (I:C) can produce 3-d mature dendritic cells.
